FI823041A7 - Farmaseuttisen yhdisteen valmistusmenetelmä. - Google Patents

Farmaseuttisen yhdisteen valmistusmenetelmä. Download PDF

Info

Publication number
FI823041A7
FI823041A7 FI823041A FI823041A FI823041A7 FI 823041 A7 FI823041 A7 FI 823041A7 FI 823041 A FI823041 A FI 823041A FI 823041 A FI823041 A FI 823041A FI 823041 A7 FI823041 A7 FI 823041A7
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical compound
pharmaceutical
compound
Prior art date
Application number
FI823041A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI823041L (fi
FI823041A0 (fi
Inventor
Barry John Price
Roy Thomas Brittain
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI823041A0 publication Critical patent/FI823041A0/fi
Publication of FI823041L publication Critical patent/FI823041L/fi
Publication of FI823041A7 publication Critical patent/FI823041A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI823041A 1981-09-04 1982-09-03 Farmaseuttisen yhdisteen valmistusmenetelmä. FI823041A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04

Publications (3)

Publication Number Publication Date
FI823041A0 FI823041A0 (fi) 1982-09-03
FI823041L FI823041L (fi) 1983-03-05
FI823041A7 true FI823041A7 (fi) 1983-03-05

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823041A FI823041A7 (fi) 1981-09-04 1982-09-03 Farmaseuttisen yhdisteen valmistusmenetelmä.

Country Status (18)

Country Link
JP (1) JPS5855421A (cg-RX-API-DMAC7.html)
KR (1) KR840001276A (cg-RX-API-DMAC7.html)
AU (1) AU8799882A (cg-RX-API-DMAC7.html)
BE (1) BE894286A (cg-RX-API-DMAC7.html)
DE (1) DE3232831A1 (cg-RX-API-DMAC7.html)
DK (1) DK396582A (cg-RX-API-DMAC7.html)
FI (1) FI823041A7 (cg-RX-API-DMAC7.html)
FR (1) FR2512343A1 (cg-RX-API-DMAC7.html)
GB (1) GB2105588B (cg-RX-API-DMAC7.html)
GR (1) GR76433B (cg-RX-API-DMAC7.html)
IL (1) IL66709A0 (cg-RX-API-DMAC7.html)
IT (1) IT8249072A0 (cg-RX-API-DMAC7.html)
LU (1) LU84364A1 (cg-RX-API-DMAC7.html)
NL (1) NL8203456A (cg-RX-API-DMAC7.html)
PT (1) PT75504A (cg-RX-API-DMAC7.html)
SE (1) SE8205035L (cg-RX-API-DMAC7.html)
ZA (1) ZA826479B (cg-RX-API-DMAC7.html)
ZW (1) ZW18582A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US20110301116A1 (en) * 2008-12-04 2011-12-08 The University Of Tokyo Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI68395C (fi) * 1979-03-02 1985-09-10 Glaxo Group Ltd Foerfarande foer framstaellning av farmakologiskt verksamma trazolfoereningar
DK446980A (da) * 1979-10-22 1981-04-23 Glaxo Group Ltd R fremgangsmaade til fremstilling af heterocycliske forbindelse

Also Published As

Publication number Publication date
IL66709A0 (en) 1982-12-31
GB2105588A (en) 1983-03-30
LU84364A1 (fr) 1984-04-24
KR840001276A (ko) 1984-04-30
FR2512343A1 (fr) 1983-03-11
FI823041L (fi) 1983-03-05
GR76433B (cg-RX-API-DMAC7.html) 1984-08-10
BE894286A (fr) 1983-03-02
DE3232831A1 (de) 1983-03-24
DK396582A (da) 1983-03-05
GB2105588B (en) 1984-07-18
SE8205035D0 (sv) 1982-09-03
SE8205035L (sv) 1983-03-05
JPS5855421A (ja) 1983-04-01
NL8203456A (nl) 1983-04-05
ZA826479B (en) 1984-04-25
FI823041A0 (fi) 1982-09-03
IT8249072A0 (it) 1982-09-03
AU8799882A (en) 1983-03-10
ZW18582A1 (en) 1984-03-28
PT75504A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
FI853477A7 (fi) Menetelmä karbonyyliyhdisteiden valmistamiseksi.
FI821422A7 (fi) Menetelmä uuden farmaseuttisen tuotteen valmistamiseksi.
ES516133A0 (es) Un procedimiento de preparacion de un compuesto.
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES530392A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
FI821397A7 (fi) Menetelmä uusien bentsodioksolijohdannaisten valmistamiseksi.
ES523501A0 (es) "un metodo para preparar derivados de 3-metilflavona".
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES507065A0 (es) Un metodo para preparar derivados de 2-oxoazetidina.
ES513408A0 (es) Un procedimiento de preparacion de alcanoles.
ES517204A0 (es) Procedimiento para preparar un derivado de nitroimidazol.
ES513409A0 (es) Un procedimiento de preparacion de alcanoles.
FI823041A7 (fi) Farmaseuttisen yhdisteen valmistusmenetelmä.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
FI822647A7 (fi) 4-amino-butyramidin valmistusmenetelmä.
ES520909A0 (es) Un metodo para la preparacion de un derivado de tilosina.
FI831051A7 (fi) Menetelmä terapeuttisesti käytettävien 2-pyrroliini-2- karbonitriili-johdannaisten valmistamiseksi.
FI821795A7 (fi) Menetelmä farmakologisesti aktiivisten - laktaamijohdannaisten valmistamiseksi.
ES518580A0 (es) Un procedimiento para preparar un derivado de aminopropilaminobleomicina.
FI820829A7 (fi) Menetelmä urean valmistamiseksi.
RO83931A (ro) Procedeu de preparare a fluorurii de izobutiril
FI820092A7 (fi) 4-amino-butyramidin valmistusmenetelmä.
FI800076A7 (fi) Menetelmä bentshydroliderivaatin valmistamiseksi.
ES520906A0 (es) Un metodo para la preparacion de un derivado de tilosina.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GLAXO GROUP LIMITED